REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/07/2025
Back to search
Official data from USPTO
ALL IN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
07/08/2025
Trademark type
Combined
Nice classes
35, 42, 44
Filing date
03/01/2018
Registration date
07/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2020
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
11
Owner location
V8Z 7X8, CA
Examiner
EBAUGH, MICHAEL
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a shaded circle, inside which is an arrow pointing to the right. To the right of the circle is the wording "ALL IN" in capital letters.
Holders and representatives
Holders
Aurinia Pharmaceuticals Inc.
Representatives
Matthew R. Wilmot STOEL RIVES LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting and raising public awareness of lupus nephritis
Class 42
Research and development activities in the field of lupus nephritis; conducting medical studies in the nature of medical and scientific research in the field of lupus nephritis; conducting clinical studies in the nature of conducting research and clinical trials for others relating to therapeutic options and pharmaceuticals in the field of lupus nephritis; conducting patient studies in the nature of evaluating new pharmaceuticals to assess feasibility for use in the treatment of lupus nephritis
Class 44
Medical information servicesproviding information to patients on lupus nephritis; conducting medical studies for medical diagnostic or treatment purposes in the field of lupus nephritis; conducting patient studies in the nature of medical evaluation servicesfunctional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessing program effectiveness
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2020
ALIE
ASSIGNED TO LIE
02/13/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/07/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/09/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/09/2019
CNSI
SUSPENSION INQUIRY WRITTEN
09/09/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/27/2019
ALIE
ASSIGNED TO LIE
08/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/10/2019
CNSL
SUSPENSION LETTER WRITTEN
01/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/19/2018
GNRT
NON-FINAL ACTION E-MAILED
06/19/2018
CNRT
NON-FINAL ACTION WRITTEN
06/19/2018
DOCK
ASSIGNED TO EXAMINER
06/14/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2018
NWAP
NEW APPLICATION ENTERED
03/05/2018
Continuous trademark protection
Get notified about every new filing that threatens ALL IN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.